Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yali Dou

Showing results (121-130 of 133) with videos related to

Pageof 14
Sort By:
Nature Communications|June 9, 2018
HuR regulates telomerase activity through TERC methylationHao Tang, Hu Wang, Xiaolei Cheng, et al.
Cancer Research|February 18, 2017
Targeted Degradation of BET Proteins in Triple-Negative Breast CancerLongchuan Bai, Bing Zhou, Chao-Yie Yang, et al.
Nature Communications|June 18, 2020
Hepatic HuR modulates lipid homeostasis in response to high-fat dietZhuojun Zhang, Chen Zong, Mingyang Jiang, et al.
Nature Communications|July 11, 2018
Author Correction: HuR regulates telomerase activity through TERC methylationHao Tang, Hu Wang, Xiaolei Cheng, et al.
International Journal of Cancer|May 4, 2023
KMT2D links TGF-β signaling to noncanonical activin pathway and regulates pancreatic cancer cell plasticityShuang Lu, Hong Sun Kim, Yubo Cao, et al.
The Journal of Clinical Investigation|February 7, 2020
Epigenetic driver mutations in ARID1A shape cancer immune phenotype and immunotherapyJing Li, Weichao Wang, Yajia Zhang, et al.
Nature Communications|May 15, 2021
Discovery of first-in-class inhibitors of ASH1L histone methyltransferase with anti-leukemic activityDavid S Rogawski, Jing Deng, Hao Li, et al.
The EMBO Journal|October 15, 2017
RBPJ/CBF1 interacts with L3MBTL3/MBT1 to promote repression of Notch signaling via histone demethylase KDM1A/LSD1Tao Xu, Sung-Soo Park, Benedetto Daniele Giaimo, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2023
Modeling kidney development, disease, and plasticity with clonal expandable nephron progenitor cells and nephron organoidsBiao Huang, Zipeng Zeng, Hui Li, et al.
The Journal of Clinical Investigation|December 20, 2019
Menin inhibitor MI-3454 induces remission in MLL1-rearranged and NPM1-mutated models of leukemiaSzymon Klossowski, Hongzhi Miao, Katarzyna Kempinska, et al.
Pageof 14

Showing results (121-130 of 133) with videos related to

Sort By:
Pageof 14
Nature Communications|June 9, 2018
HuR regulates telomerase activity through TERC methylationHao Tang, Hu Wang, Xiaolei Cheng, et al.
Cancer Research|February 18, 2017
Targeted Degradation of BET Proteins in Triple-Negative Breast CancerLongchuan Bai, Bing Zhou, Chao-Yie Yang, et al.
Nature Communications|June 18, 2020
Hepatic HuR modulates lipid homeostasis in response to high-fat dietZhuojun Zhang, Chen Zong, Mingyang Jiang, et al.
Nature Communications|July 11, 2018
Author Correction: HuR regulates telomerase activity through TERC methylationHao Tang, Hu Wang, Xiaolei Cheng, et al.
International Journal of Cancer|May 4, 2023
KMT2D links TGF-β signaling to noncanonical activin pathway and regulates pancreatic cancer cell plasticityShuang Lu, Hong Sun Kim, Yubo Cao, et al.
The Journal of Clinical Investigation|February 7, 2020
Epigenetic driver mutations in ARID1A shape cancer immune phenotype and immunotherapyJing Li, Weichao Wang, Yajia Zhang, et al.
Nature Communications|May 15, 2021
Discovery of first-in-class inhibitors of ASH1L histone methyltransferase with anti-leukemic activityDavid S Rogawski, Jing Deng, Hao Li, et al.
The EMBO Journal|October 15, 2017
RBPJ/CBF1 interacts with L3MBTL3/MBT1 to promote repression of Notch signaling via histone demethylase KDM1A/LSD1Tao Xu, Sung-Soo Park, Benedetto Daniele Giaimo, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2023
Modeling kidney development, disease, and plasticity with clonal expandable nephron progenitor cells and nephron organoidsBiao Huang, Zipeng Zeng, Hui Li, et al.
The Journal of Clinical Investigation|December 20, 2019
Menin inhibitor MI-3454 induces remission in MLL1-rearranged and NPM1-mutated models of leukemiaSzymon Klossowski, Hongzhi Miao, Katarzyna Kempinska, et al.
Pageof 14